Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

Hayley C Whitaker

Hayley C Whitaker

Hayley C Whitaker
Uro-Oncology Research Group, UK Cambridge Research Institute, United Kingdom


Dr. Hayley C Whitaker was research Associate in UK Cambridge Research Institute Ribson Way.

Research Interest

Androgens and the AR are essential for prostate cancer growth and development and if we can bypass this pathway we may be able to target cancer. Following treatment with antiandrogens prostate cancer becomes hormone resistant and we do not understand how this transition occurs. The current test for prostate cancer is the PSA test but this frequently gives false positives and negatives so we are looking for a new biomarker for either the development of prostate cancer or its progression to the hormone resistant form.

Recommended Conferences

World Biotechlogy Congress 2020

Barcelona, Spain


tempobet giriş

tempobet giriş


tipobet yeni giriş adresi tipobet e yeni giriş tipobet güncel giriş adresi imajbet giriş adresi

mobilbahis giriş

arrow_upward arrow_upward